Lilly vs. Novo in 2026’s Biggest Pharma Showdown — Which Obesity Pill Will Win America’s $44 Billion Weight-Loss Drug War?
Eli Lilly’s Foundayo just got FDA approval in 50 days flat — and Wall Street is already projecting $21 billion in sales. But Novo Nordisk has a secret weapon in its…
Read More